Surrogacy Guide

Do Chinese hospitals offer patient testimonial services for assisted reproduction? This article explains what patient testimonials mean, how to access real cases in domestic hospitals, family accompaniment policies, and privacy protection regulations. Learn how to obtain successful case references through official channels, as well as witnessing arrangements and precautions during treatment.

The core of the China IVF self-help guide lies in planning examinations in advance, choosing the right hospital, and mastering key time points. This article breaks down each stage of IVF in a monthly timeline format, including examination items for both men and women, ovulation induction and egg retrieval, precautions before and after embryo transfer, and compares differences between public and private hospitals, helping those seeking pregnancy avoid common pitfalls and complete the cycle efficiently.

China's egg freezing technology uses vitrification with a survival rate exceeding 90%. This article analyzes the current technology status, eligible candidates, age impact, procedures, and costs from a reproductive doctor's perspective, clarifying the policy boundaries between medical and social egg freezing to help make informed decisions.

Chinese embryologist qualifications can be verified through the National Health Commission official website, provincial health commission announcements, hospital on-site displays, and the Chinese Medical Doctor Association. This article details embryologist certification standards, verification steps, document preparation, and common misconceptions to help patients accurately confirm embryologist practice qualifications.

Microdissection Testicular Sperm Extraction (Micro-TESE) is a key technique in the diagnosis and treatment of male infertility in China, suitable for patients with non-obstructive azoospermia. It involves fine separation of testicular tissue under a microscope to find sperm, with success rates related to individual etiology. This article covers the technical principles, surgical procedure, suitable candidates, and risks.

When choosing a hospital for patients with repeated implantation failure (RIF), it is essential to focus on embryo laboratory capabilities, endometrial receptivity assessment, immune diagnosis and treatment levels, reproductive surgery techniques, and multidisciplinary consultation mechanisms. This article analyzes the specialized areas of major Chinese reproductive centers from a medical perspective, helping patients match suitable medical resources based on their own etiology and avoid blind choices.

China's embryo dynamic grading system combines time-lapse imaging technology with traditional morphological assessment to dynamically monitor the entire embryo development process. The system grades embryos at D3/D5/D6 stages based on indicators such as blastomere number, fragmentation rate, and cell uniformity, assisting in the selection of embryos for transfer. Grading standards vary among different reproductive centers, and a unified national scoring system is lacking.

To find a certified fertility center in China, verify against the 'List of Medical Institutions Approved to Provide Assisted Reproductive Technology' on the National Health Commission's official website. This guide provides a complete verification process: log in to the NHC website, search for assisted reproductive technology, download the latest list, and check the institution's name and technology scope. It also explains key points for identifying permits, common verification mistakes, and criteria for judging practitioners, helping users accurately identify legitimate fertility centers.

The latest version of China's human assisted reproductive technology regulations systematically stipulates institutional qualifications, staffing, operational procedures, and ethical review. From a medical editor's perspective, this article interprets the core changes, implementation standards, and actual impact on patients and institutions, helping readers accurately understand the current regulatory system and compliance requirements.

IVM (In Vitro Maturation) technology is an important technique in the field of assisted reproduction, suitable for patients with polycystic ovary syndrome, high ovarian responders, etc. This article systematically answers how IVM technology works in China, who it is suitable for, and what precautions to take, from the perspectives of technical principles, target populations, clinical procedures, success rates, and risks.

Answers the question of embryo cryopreservation duration in China. Introduces the industry consensus of a 5-10 year storage period, actual implementation policies and storage fee standards of various reproductive centers, renewal and disposal methods upon expiration, and key storage agreement terms and renewal reminders patients need to be aware of.

How to check the success rate of Chinese hospitals? This article introduces methods to query assisted reproduction success rates through official channels such as the National Health Commission website, provincial health commission announcements, reproductive center annual reports, and academic journals. It also explains data statistical calibers, age stratification, and live birth rate differences to help patients rationally reference real data.

All regular hospitals in China are required to have medical liability insurance (malpractice insurance), including assisted reproduction centers. This article explains insurance coverage, how patients can verify hospital qualifications, the process for handling disputes, and key considerations for determining medical liability related to IVF.

This article summarizes information on hospitals in China that have obtained ISO certification in the field of assisted reproduction, explains the differences between ISO 9001 and ISO 15189 certification, provides methods for querying certification lists, and helps patients understand the reference value of certification when choosing a reproductive center.

Outpatient appointments at general Chinese hospitals typically do not require a deposit. However, for assisted reproduction treatments (IVF), due to special procedures like ovulation induction, egg retrieval, and embryo culture, most fertility centers require an upfront deposit. The deposit amount varies by hospital, treatment plan, and individual circumstances, generally ranging from 5,000 to 30,000 RMB. This article details the deposit policies, payment procedures, and important considerations for assisted reproduction hospitals.

Chinese law explicitly prohibits any form of commercial surrogacy. According to the 'Administrative Measures on Human Assisted Reproductive Technology', medical institutions and intermediaries are not allowed to perform or organize surrogacy. This article details the legal basis, consequences of violations, and legal fertility pathways, including alternatives such as IVF and adoption.

The environments of assisted reproduction hospitals in China vary significantly: public tertiary reproductive centers prioritize medical functionality with practical settings but high patient traffic; private specialized hospitals focus on service experience with comfortable environments but higher costs. This article analyzes the environmental characteristics, selection logic, and common misconceptions of different hospitals from a real medical perspective.

Based on regulations such as the Administrative Measures on Human Assisted Reproductive Technology, this article systematically reviews China's surrogacy laws and policies. It clarifies that surrogacy is prohibited in China, analyzing legal basis, consequences of violations, common misconceptions, and legal assisted reproduction pathways. It helps the public accurately understand policy boundaries and avoid legal risks.

Evaluating reproductive hospitals in China requires comprehensive consideration of multiple factors including qualification certification, clinical pregnancy rate, laboratory level, doctor team, and individual matching. This article provides an objective selection framework from the perspective of reproductive medicine to help patients establish a rational decision-making path and avoid common selection pitfalls.

Based on real patient feedback and industry standards, analyze the core dimensions of assisted reproduction hospital environment assessment: patient flow, embryo lab cleanliness level, privacy protection, service process, etc. No specific institutions are recommended, providing actionable selection references.